NSG 552 - Psychopharmacology Exam

NSG 552 - Psychopharmacology Exam #2 QUESTIONS AND ANSWERS
First-line treatment for PTSD - ANSWER SSRI

- Sertraline

- Citalopram

SNRI

- Venlafaxine



Neurological conditions that mimic/worsen anxiety symptoms (7) - ANSWER - Epilepsy

- Encephalitis

- Early dementia

- MS

- Migraine

- Meniere's

-Cerebrovascular disease



Stimulant FDA-approved for binge eating - ANSWER lisdexamfetamine (Vyvanse)



Considerations for patient with comorbid substance use and anxiety - ANSWER - Non-addictive
anxiolytic alternative (e.g., neurontin)

- Antihistamines with anxiolytic properties (e.g., Benadryl, hydroxyzine)



FDA-approved for bulimia - ANSWER Fluoxetine



Buspirone mechanism of action - ANSWER Partial agonist at 5HT-1A (decrease serotonergic activity)

, SSRIs - ANSWER May be helpful for patients with illness anxiety and comorbid anxiety/depressive
symptoms



Benzodiazepines recommended for patients with liver disease or alcoholism (3) - ANSWER - Oxazepam

- Temazepam

- Lorazepam



Clinical manifestations of benzodiazepine withdrawal (8) - ANSWER - Anxiety

- Anorexia

- Insomnia

- Irritability

- Hand tremors

- Autonomic hyperactivity (diaphoresis, tachycardia, HTN)

- Nausea, vomiting

- Tonic-clonic seizures



Antidepressants used for insomnia - ANSWER - Elaviol

- Doxepin

- Mirtazapine

- Trazodone



Modafinil - ANSWER First-line treatment for narcolepsy



Benzodiazepine mechanism of action - ANSWER Potentiate effects of GABA



Mood stabilizers used for RLS management - ANSWER - Gabapentin